↓ Skip to main content
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (97th percentile)
So far, Altmetric has seen
3 Reddit threads by 3 users.
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
User daadaad, in the COVID-19 Discussion subreddit,
Chinese phase 2 clinical trial of Non-replicating adenovirus type-5 (Ad5)-vectored COVID-19 found to be safe and induces an immune response. No serious adverse reactions were noted. Phase 3 trials needed to confirm its effectiveness against SARS-CoV-2.
User Hamz45, in the Reddit Science subreddit,
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet
User przemkas,